Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SETD1B | Q9UPS6 | 1/20 | 0.65 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21533448 | 0.90 | SETD1B (0.80) | SETD1B | |
| SCHEMBL21533615 | 0.90 | SETD1B (0.64) | SETD1B | |
| SCHEMBL21533594 | 0.90 | SETD1B (0.67) | SETD1B | |
| SCHEMBL21533556 | 0.88 | SETD1B (0.82) | SETD1B | |
| SCHEMBL21533534 | 0.88 | SETD1B (0.69) | SETD1B | |
| SCHEMBL21533493 | 0.84 | ALDH1A1 (0.62) | — | |
| SCHEMBL21533505 | 0.84 | SETD1B (0.72) | SETD1B | |
| SCHEMBL21533449 | 0.81 | SETD1B (0.77) | SETD1B | |
| SCHEMBL21533446 | 0.81 | SETD1B (0.80) | SETD1B | |
| SCHEMBL21533614 | 0.79 | SETD1B (1.00) | SETD1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190330167-A1 | ACTIVATORS OF HIV LATENCY | THE WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH (AU) | 2019-10-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190330167-A1 | ACTIVATORS OF HIV LATENCY | NFATC1, EP300, CD69 | SETD1B 2024/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.